产品特点
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Dianette 2mg/35micrograms coated tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 2.0 mg cyproterone acetate and 0.035 mg ethinylestradiol.
Excipients:
Lactose monohydrate
31.115mg
Sucrose
19.371mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Coated tablet (tablet).
_Product imported from the UK:_
Beige, sugar-coated, biconvex tablets
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For use in the management of severe acne vulgaris, especially those forms which are accompanied by seborrhoea or by
inflammation or formation of nodes (acne papulopustulosa, acne nodulocystica) in women.
Oral contraception for the woman suffering from the above.
Although Dianette also acts as an oral contraceptive, it should not be used in women solely for contraception, but
should be reserved for those women requiring treatment for the androgen-dependent acne described.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
HOW TO TAKE DIANETTE
Dianette is to be taken regularly in order to achieve the therapeutic efficacy and the required contraceptive protection.
Combined oral contraceptives when taken correctly have a failure rate of approximately 1% per year.
Tablets must be taken in the order directed on the package every day at about the same time with some liquid as
needed. One tablet is to be taken daily for 21 consecutive days. Each subsequent pack is started after a 7-day tablet-
free interval, during which time a withdrawal bleed usually occurs.
This usually starts on day 2-3 after the last tablet and may not have finished before the next pack is started.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date
阅读完整的文件
产品特点 